Kamada Ltd
KMDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567529
In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Kamada Ltd changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 30 | 1 | 30 | +1 |
| Shares | 6.37M | 11.7K | 6.47M | +114.7K (+1.8%) |
| Value | $31.7M | $57.9K | $34.8M | +$3.14M (+9.9%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Kamada Ltd at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Plato Investment Management Ltd | 21,785 | $117.1K | 0.01% |
| Baader Bank INC | 20,000 | $107.4K | 0.01% |
| GWM Advisors LLC | 15,236 | $81.8K | 0.00% |
| Public Employees Retirement System of Ohio | 14,270 | $76.8K | 0.00% |
| BlackRock, Inc. | 11,683 | $62.7K | 0.00% |
| Farther Finance Advisors, LLC | 39 | $209 | 0.00% |
Sold out (5)
Institutions that held Kamada Ltd at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| JPMorgan Chase & Co | 151,949 | $753.7K |
| Susquehanna International Group, LLP | 26,321 | $131.6K |
| Mather Group, LLC. | 400 | $2.24K |
| UBS Group AG | 276 | $1.37K |
| Qube Research & Technologies Ltd | 1 | $5 |
Not filed for Q3 2024 yet (1)
Institutions that held Kamada Ltd at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 11,683 | $57.9K |